HCA
Harbor Capital Advisors Portfolio holdings
AUM
$2.38B
1-Year Return
20%
This Quarter Return
+12.08%
1 Year Return
+20%
3 Year Return
+97.89%
5 Year Return
–
10 Year Return
–
AUM
$765M
AUM Growth
+$245M
(+47%)
Cap. Flow
+$204M
Cap. Flow
% of AUM
26.68%
Top 10 Holdings %
Top 10 Hldgs %
18.2%
Holding
888
New
450
Increased
153
Reduced
141
Closed
144
Top Buys
| 1 |
Amazon
AMZN
|
$15.2M |
| 2 |
JPMorgan Chase
JPM
|
$11.7M |
| 3 |
Caterpillar
CAT
|
$3.85M |
| 4 |
GE Aerospace
GE
|
$3.69M |
| 5 |
Applied Materials
AMAT
|
$3.36M |
Top Sells
| 1 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
$17M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$7.29M |
| 3 |
Merck
MRK
|
$5.47M |
| 4 |
Affirm
AFRM
|
$4.35M |
| 5 |
NVIDIA
NVDA
|
$3.86M |
Sector Composition
| 1 | Technology | 26.41% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Usana Health Sciences
USNA
$581M
| $446K | 0.06% |
9,193
+2,911
| +46% | +$141K |
|
427
Atmus Filtration Technologies
ATMU
$3.79B
| $445K | 0.06% |
+13,798
| New | +$445K |
|
428
Idexx Laboratories
IDXX
$51.4B
| $445K | 0.06% |
825
+28
| +4% | +$15.1K |
|
429
Legend Biotech
LEGN
$6.66B
| $443K | 0.06% |
7,904
+1,864
| +31% | +$104K |
|
430
Thor Industries
THO
$5.94B
| $443K | 0.06% |
+3,778
| New | +$443K |
|
431
Texas Roadhouse
TXRH
$11.2B
| $439K | 0.06% |
+2,843
| New | +$439K |
|
432
Kennedy-Wilson Holdings
KW
$1.21B
| $434K | 0.06% |
+50,619
| New | +$434K |
|
433
Allogene Therapeutics
ALLO
$255M
| $433K | 0.06% |
96,837
+23,327
| +32% | +$104K |
|
434
Maximus
MMS
$4.97B
| $432K | 0.06% |
+5,151
| New | +$432K |
|
435
DocGo
DCGO
$155M
| $428K | 0.06% |
106,051
+56,871
| +116% | +$230K |
|
436
Enterprise Financial Services Corp
EFSC
$2.24B
| $426K | 0.06% |
+10,496
| New | +$426K |
|
437
Principal Financial Group
PFG
$17.8B
| $426K | 0.06% |
4,935
+1,010
| +26% | +$87.2K |
|
438
Patterson-UTI
PTEN
$2.18B
| $424K | 0.06% |
35,514
-150,270
| -81% | -$1.79M |
|
439
Gartner
IT
$18.6B
| $423K | 0.06% |
+888
| New | +$423K |
|
440
Jones Lang LaSalle
JLL
$14.8B
| $422K | 0.06% |
+2,165
| New | +$422K |
|
441
Tarsus Pharmaceuticals
TARS
$2.43B
| $422K | 0.06% |
+11,620
| New | +$422K |
|
442
Hubbell
HUBB
$23.2B
| $420K | 0.05% |
1,012
+65
| +7% | +$27K |
|
443
Primerica
PRI
$8.85B
| $416K | 0.05% |
+1,643
| New | +$416K |
|
444
Molina Healthcare
MOH
$9.47B
| $415K | 0.05% |
+1,009
| New | +$415K |
|
445
Nextracker
NXT
$10.4B
| $415K | 0.05% |
+7,375
| New | +$415K |
|
446
International Bancshares
IBOC
$4.45B
| $412K | 0.05% |
+7,341
| New | +$412K |
|
447
MoonLake Immunotherapeutics
MLTX
$3.77B
| $412K | 0.05% |
+8,208
| New | +$412K |
|
448
Trade Desk
TTD
$25.5B
| $406K | 0.05% |
4,641
-2,869
| -38% | -$251K |
|
449
First Solar
FSLR
$22B
| $405K | 0.05% |
+2,398
| New | +$405K |
|
450
Healthpeak Properties
DOC
$12.8B
| $404K | 0.05% |
+21,537
| New | +$404K |
|